Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.90
Delayed Data
As of Dec 11
 +0.05 / +1.75%
Today’s Change
1.93
Today|||52-Week Range
3.55
+36.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
AssetsCash147.2M314.3M349.4M510.1M
 
 
 
 
 
Short Term Investment Cash40.6M167.2M35.1M160.7M
 
 
 
 
 
Cash & Short Term Investments242.1M409.3M435.3M516.5M
 
 
 
 
 
 
ReceivablesReceivables151.3M125.3M83.2M75.0M
 
 
 
 
 
 
InventoriesInventories2.9M3.5M11.5M12.2M
 
 
 
 
 
 
Current AssetsOther Current Assets1.7M5.9M6.9M9.5M
 
 
 
 
 
Current Assets398.0M544.0M536.8M613.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross9.2M------
 
 
Depreciation-9.2M------
 
 
Intangible Assets630.9M516.3M571.3M574.0M
 
 
 
 
 
Other Assets638.3M523.8M573.1M575.2M
 
 
 
 
 
Total Assets1.2B1.2B1.3B1.2B
 
 
 
 
 
 
LiabilitiesAccounts Payable7.0M18.0M10.4M10.4M
 
 
 
 
 
Short Term Debt0.00122.7M123.8M124.9M
 
 
 
 
Accrued Expenses24.9M30.2M25.3M23.7M
 
 
 
 
 
Other Current Liabilities115.4M121.0M119.9M43.2M
 
 
 
 
 
Other Liabilities130.3M275.3M276.3M194.1M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt232.4M112.4M114.0M115.7M
 
 
 
 
 
Deferred Taxes-19.3M-11.7M-18.2M-6.2M
 
 
 
 
 
Other Liabilities13.0M13.6M14.9M15.5M
 
 
 
 
 
Total Liabilities460.0M474.8M483.2M400.9M
 
 
 
 
 
 
EquityMinority Interest-56.0K-47.0K0.000.00
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity751.1M758.7M818.8M823.0M
 
 
 
 
 
Total Shareholder Equity751.1M758.7M818.8M823.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding165.5M163.7M154.1M154.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.